Abigail Victoria Rutter

Dr. Abigail Victoria Rutter

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2012 in The Analyst
Verified
Journal Article
Closed access
PDF file
ARAbigail Victoria Rutter
Abigail Victoria Rutter
TCThomas W. E. Chippendale
Thomas W. E. Chippendale
YYYing Yang
Ying Yang
PŠPatrik Španěl
Patrik Španěl
DSDavid Smith
David Smith
JSJosep Sulé-Suso
Josep Sulé-Suso
Our previous studies have shown that both lung cancer cells and non-malignant lung cells release acetaldehyde in vitro. However, data from other laboratories have produced conflicting results. Furthermore, all these studies have been carried out in 2D models which are less physiological cell growth systems when compared to 3D models. Therefore, we have carried out further work on the release of acetaldehyde by lung cells in 3D collagen hydrogels. Lung cancer cells CALU-1 and non-malignant lung cells NL20 were seeded in these hydrogels at different cell concentrations and the release of acetaldehyde was measured with the Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) technique. The data obtained showed that the amount of acetaldehyde released by both cell types grown in a 3D model is higher when compared to that of the same cells grown in 2D models. More importantly, acetaldehyde from the headspace of lung cancer cells could be measured even at a low cell concentration (105 cells per hydrogel). The differential of acetaldehyde release could be, depending on the cell concentration, more than 3 fold higher for cancer cells when compared to non-malignant lung cells. This pilot study is the first to study acetaldehyde emission from albeit only two cell types cultured in 3D scaffolds. Clearly, from such limited data the behaviour of other cell types and of tumour cells in vivo cannot be predicted with confidence. Nevertheless, this work represents another step in the search for volatile biomarkers of tumour cells, the ultimate goal of which is to exploit volatile compounds in exhaled breath and other biological fluids as biomarkers of tumours in vivo.

20 May 2014 in Cytometry Part A
Verified
Journal Article
Closed access
PDF file
ARAbigail Victoria Rutter
Abigail Victoria Rutter
MSMuhammad R. Siddique
Muhammad R. Siddique
JFJacob Filik
Jacob Filik
CSChristophe Sandt
Christophe Sandt
PDPaul Dumas
Paul Dumas
JSJosep Sulé‐Suso
Josep Sulé‐Suso

9 July 2013 in The Analyst
Verified
Journal Article
Closed access
PDF file
JPJacek K. Pijanka
Jacek K. Pijanka
NSNick Stone
Nick Stone
ARAbigail Victoria Rutter
Abigail Victoria Rutter
NFNicholas Forsyth
Nicholas Forsyth
GSGanesh D. Sockalingum
Ganesh D. Sockalingum
JSJosep Sulé-Suso
Josep Sulé-Suso
Raman spectroscopy has been widely used to study its possible clinical application in cancer diagnosis. However, in order to make it into clinical practice, it is important that this technique is able not only to identify cancer cells from their normal counterparts, but also from the array of cells present in human tissues. To this purpose, we used Raman spectroscopy to assess whether this technique was able to differentiate not only between lung cancer cells and lung epithelial cells but also from lung fibroblasts. Furthermore, we studied whether the differences were due to cell lineage (epithelial versus fibroblast) or to different proliferative characteristics of cells, and where in the cell compartment these differences might reside. To answer these questions we studied cell cytoplasm, cell nucleus and isolated whole cell nuclei. Our data suggests that Raman spectroscopy can differentiate between lung cancer, lung epithelial cells and lung fibroblasts. More important, it can also differentiate between 2 cells from the same lineage (fibroblast) but with one of them rendered immortal and with an increased proliferative activity. Finally, it seems that the main spectral differences reside in the cell nucleus and that the study of isolated nuclei strengthens the differences between cells.

17 October 2018 in The Analyst
Verified
Journal Article
Closed access
PDF file
ARAbigail Victoria Rutter
Abigail Victoria Rutter
JCJ. Crees
J. Crees
HWH. Wright
H. Wright
DPD. G. van Pittius
D. G. van Pittius
IYIbraheem Yousef
Ibraheem Yousef
JSJ. Sulé-Suso
J. Sulé-Suso
Over the last few years, great effort has been placed on developing Fourier Transform Infrared (FTIR) microspectroscopy as a tool to help in the histopathological diagnosis of cancer. The ever increasing workload in pathology departments is calling for a technique that could identify the presence of cancer cells in cytology and tissue samples in an objective, fast and automated way. However, pathologists use glass slides which absorb infrared (IR) radiation thus removing important mid-IR spectral data in the fingerprint region (proteins, DNA, RNA; 1800 cm−1 to 900 cm−1). To this purpose, we hypothesised whether using thinner glass slides, i.e., glass coverslips, would allow us to obtain spectral data not only from the lipid region (3100 cm−1 to 2700 cm−1) but also from the fingerprint region. To this purpose, we studied peripheral blood mononuclear cells (PBMC), a leukaemia cell line (K562) and a lung cancer cell line (CALU-1). Cells were placed on DAKO coverslips and their FTIR spectra obtained at MIRAS beamline, Alba synchrotron light source (Barcelona, Catalonia). The data presented here not only shows for the first time that it is possible to obtain spectral data from most of the amide I region (1800 cm−1 to 1570 cm−1) of cells placed on glass coverslips but more important, principal component analysis was able to separate between the three types of cells for both the lipid and the amide I regions. The methodology here described is a further step in the application of FTIR microspectroscopy in histopathology departments.

8 December 2016 in The Analyst
Verified
Journal Article
Closed access
PDF file
MSM. R. Siddique
M. R. Siddique
ARAbigail Victoria Rutter
Abigail Victoria Rutter
KWK. Wehbe
K. Wehbe
GCGianfelice Cinque
Gianfelice Cinque
GBG. Bellisola
G. Bellisola
JSJ. Sulé-Suso
J. Sulé-Suso
S-FTIR and Raman microspectroscopies identify spectral markers of sensitivity/resistance to nilotinib in leukaemia cell clones.

10 July 2017 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
VSVioletta Shestivska
Violetta Shestivska
ARAbigail Victoria Rutter
Abigail Victoria Rutter
JSJosep Sulé‐Suso
Josep Sulé‐Suso
DSDavid Smith
David Smith
PŠPatrik Španěl
Patrik Španěl